HKG:6826 Market Cap

HKG:6826 has a market cap or net worth of 9.96 billion as of March 6, 2026. Its market cap has decreased by -23.11% in one year.

Market Cap

9.96B

Enterprise Value

7.83B

Revenue

2.75B

Ranking

n/a

PE Ratio

20.09

Stock Price

24.14

Market Cap Chart

Since April 30, 2015, HKG:6826's market cap has increased from 9.34B to 9.96B, an increase of 6.59%. That is a compound annual growth rate of 0.59%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	9.96B	-2.05%
Dec 31, 2025	10.17B	-23.81%
Dec 31, 2024	13.35B	-24.15%
Dec 29, 2023	17.60B	7.10%
Dec 30, 2022	16.43B	-29.33%
Dec 31, 2021	23.25B	40.30%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Keymed Biosciences	14.14B
Everest Medicines	12.51B
Guangzhou Innogen Pharmaceutical Group	10.39B
Nanjing Leads Biolabs	10.27B
HBM Holdings	9.76B
CStone Pharmaceuticals	9.47B
Abbisko Cayman	7.62B
CK Life Sciences Int'l., (Holdings)	7.59B

Market Cap Rankings